Loading company…
Prolira develops medical devices for detecting acute encephalopathy and delirium.
Founded in 2015, Prolira develops the DeltaScan® Brain State Monitor, a device for detecting acute encephalopathy and delirium. It is based in Utrecht, Netherlands, and serves hospitals and healthcare providers. In February 2022, the company raised EUR 5.000 mn, with StartGreen Capital, Health Innovations, Holland Capital, Oost NL, and ROM Utrecht Region among the investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in